Navigation Links
Morgan & Morgan Announces Investigation of MAP Pharmaceuticals (NASDAQ: MAPP)
Date:1/30/2013

NEW YORK, Jan. 30, 2013 /PRNewswire/ -- Morgan & Morgan is investigating the Board of Directors of MAP Pharmaceuticals Inc. ("MAP" or the "Company") (Nasdaq: MAPP) for possible breaches of fiduciary duty and other violations of law related to the sale of the Company to Allergan Inc.

If you are a current shareholder of MAP and are interested in learning more about our MAP Pharmaceuticals merger investigation, please contact George Pressly, Esq. at 1 (800) 631-6234 or email George at info@morgansecuritieslaw.com.

Under the terms of the transaction, MAP shareholders will receive $25 for each share of MAP stock they own. The transaction has a total approximate value of $958 million. The investigation concerns whether the MAP Board of Directors has breached its fiduciary duties to act in the best interests of MAP shareholders and to take all necessary steps to ensure that MAP shareholders receive the maximum value readily available for their shares of MAP common stock.

About Morgan & Morgan
Morgan & Morgan is one of the nation's largest 200 law firms. In addition to securities fraud, the firm also practices in the areas of antitrust, personal injury, consumer protection, overtime, and product liability.  All of the Firm's legal endeavors are rooted in its core mission: provide investor and consumer protection and always fight "for the people." 

Attorney advertising. Prior results do not guarantee a similar outcome.

Contact:
Morgan & Morgan
Peter Safirstein, Esq.
28 West 44th Street
Suite 2001
New York, NY  10036
1-800-631-6234
info@morgansecuritieslaw.com


'/>"/>
SOURCE Morgan & Morgan
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Elsevier / Gold Standards Kay Morgan Awarded NCPCP Highest Honor
2. Zimmer Holdings to Present at Morgan Stanley 2012 Global Healthcare Conference
3. Accuray Incorporateds CEO to Speak at Morgan Stanley Global Healthcare Conference
4. Watson to Present at the Morgan Stanley 2012 Global Healthcare Conference
5. Hill-Rom to Participate in the Morgan Stanley Global Healthcare Conference
6. Hologic To Participate In The Morgan Stanley Global Healthcare Conference
7. Abaxis, Inc. to Present at the Morgan Stanley Global Healthcare Conference
8. Cyberonics To Present At Morgan Stanley 2012 Global Healthcare Conference
9. Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference
10. Depomed To Present At Morgan Stanley 2012 Healthcare Conference
11. Boston Scientific to Participate in the 2012 Morgan Stanley Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)...  CVS Pharmacy, the retail division of CVS ... design to enhance the retail customer experience with ... and expanded beauty selections paired with informational signage ... offerings. Together with its innovative digital programs, these ... experience at CVS Pharmacy.  "Pharmacy ...
(Date:4/20/2017)... Research and Markets has announced the ... Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies ... ... was valued at US$ 7,167.6 Mn in 2015, and is ... a CAGR of 5.6% from 2016 to 2024. ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio ... These lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most ... disconnect ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... been previously exposed to more adverse experiences than children in the general population. ... such as abuse, neglect or other family challenges. While no fault of their ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... or hERG liability could substantially improve drug safety and minimize the cost of ... for validating ion channel inhibition using cell lines and for cardiac toxicity using ...
(Date:4/28/2017)... ... ... Overseer at The House of Yahweh in Abilene, Texas, has published a new post that ... Yisrayl says with so many titles and names for the Creator, it’s hard for many ... Scripture, backed with a lot of research, the truth is undeniable. , “If you ...
(Date:4/28/2017)... ... ... Intellitec Solutions announced the publication of a case study ... solution that integrates to their PointClickCare EHR software package. With the guidance of ... now has the capability to achieve its goal for a comprehensive EHR solution, ...
Breaking Medicine News(10 mins):